EXCLUSIVE: Enosis Therapeutics & Ovid Clinics Develop World's First In-Clinic VR For Psychedelic Therapy - Benzinga

Australian biotech psychedelics start-up Enosis Therapeutics has partnered with Berlin-based healthcare services supplier OVID Clinics and the MIND Foundation to acceptable up a aviator program to make the world’s archetypal in-clinic exertion of virtual world (VR) concurrently with psychedelic-assisted therapy. 

Enrollment for the inaugural VR program, VRPP, is unfastened present done OVID’s web of clinics. The caller connection entails that patients volition get the accidental to person ketamine-assisted psychotherapy integrated with Enosis’ science-backed virtual exertion therapy protocols and modules.

“Enosis is delighted to person recovered a objective spouse who shares our values and our imaginativeness that exertion tin beryllium a tool, erstwhile utilized appropriately, towards improving the diligent acquisition and therapeutic outcomes,” said Agnieszka Sekula, Enosis co-founder and psychedelics researcher. 

“This is simply a cardinal milestone for Enosis arsenic we instrumentality the adjacent measurement and apply our probe to practice. We are arrogant to put our VR models into the hands of the OVID squad and their therapy protocols to present a affirmative therapeutic acquisition to patients successful need,” she said.

On behalf of OVID, co-founder and CEO Dr. Sergio Pérez Rosal stated: “At OVID Clinics, we judge successful a personalized, evidence-based, aesculapian and psychotherapeutic attack tailored to the patient's needs. We admit the worth of Enosis´ VR technologies successful the integration process pursuing psychedelic therapy.”

Earlier this year, Enosis and the Swinburne University of Technology successful Australia led the world’s archetypal study connected the synergistic exertion of VR successful psychedelics, which delivered affirmative outcomes successful which preliminary results showed that Enosis VR scenarios combined with a guided psychedelic acquisition generated precocious levels of acceptance and satisfaction. 

This study’s findings triggered the thought of offering proprietary VR exertion for wider in-clinic use.

“Enhancing diligent accessibility to our VR experiences remains our apical precedence and we are excited to bring this caller attraction to patients successful need," Sekula said. "Together with the OVID team, our absorption is to execute affirmative diligent outcomes and longer-lasting therapeutic benefits for patients battling intelligence wellness illnesses.”

Rosal added that OVID’s team is convinced that the contiguous concern volition assistance innovate the tract by shifting the absorption from the psychedelic substance to the psychedelic acquisition and its integration, supporting patients passim their full travel into a authorities of well-being.

Additionally, the Enosis-OVID concern will stitchery information for a probe collaboration toward investigating the synergistic effects of psychedelic and integer interventions.

A Deeper Look Into The Collaborators’ Individual Work

The European MIND Foundation is simply a not-for-profit subject and acquisition enactment promoting psychedelic probe and therapy. MIND besides offers psychedelic-assisted therapy grooming to physicians and psychotherapists. Its Augmented Psychotherapy Training (APT) has integer interventions included successful the curriculum.

MIND’s objective spouse is OVID. The German-based web of clinics performs psychedelics probe and improvement arsenic good arsenic assisted therapy. Its SAND protocol foresees the implementation of serotonergic and atypical psychedelic substances arsenic good as non-pharmacological and integer interventions to beforehand intelligence health. 

Enosis intends to find astatine the intersection of probe and industry, providing designed VR scenarios and objective protocols that employment them astatine circumstantial points of psychedelic-assisted psychotherapy to amended the prime of the diligent acquisition and therapy outcomes.

The projected therapeutic attack promotes non-cognitive, experiential, affectional and embodied aspects of treatment. The crushed down it is that along with co-founder and long-time psychedelics advocator Dr. Prashanth Puspanathan, the Enosis enactment seeks to empower patients to actively nonstop their ain healing travel by utilizing VR to interruption distant from the constraints of the analog system. 

Photo courtesy of Enosis (cofounder Agnieszka D. Sekula).